FOR IMMEDIATE RELEASE
n
Washington D.C. – August 25th, 2026 – In a significant stride towards transforming epilepsy care and research across the United States, Epilepsy Alliance America (EAA) proudly announces the publication of a landmark article in Epilepsy Currents. The comprehensive piece, titled "A Unified Vision: Forging a National Plan for Epilepsy," outlines the critical need for a coordinated national strategy to address the profound challenges faced by 3.4 million Americans living with epilepsy. The publication is poised to ignite renewed advocacy and collaboration among stakeholders, aiming to bridge existing gaps in research funding, public awareness, and access to optimal care.
n
The article serves as a powerful call to action, detailing how a harmonized national plan could dramatically improve outcomes for patients and their families nationwide. It emphasizes that while individual organizations have made commendable progress, the complexity and pervasive nature of epilepsy demand a unified, multi-faceted approach to achieve lasting, systemic change.
n
n
Main Facts: A Call for Unified Action
n
The core message of the Epilepsy Currents publication, championed by Epilepsy Alliance America and its esteemed partners, is unequivocal: the fragmented landscape of epilepsy research, advocacy, and care in the United States is no longer sustainable. The article highlights that despite epilepsy being one of the most common neurological conditions, its societal burden remains immense, exacerbated by persistent deficiencies in several key areas.
n
Specifically, the publication underscores three primary challenges:
n
- n
- Significant Gaps in Research Funding: Compared to other chronic conditions of similar prevalence and impact, epilepsy research consistently receives disproportionately less funding. This deficit hampers scientific discovery, delays the development of innovative treatments, and limits understanding of the underlying mechanisms of seizures and the progression of epilepsy.
- Insufficient Public Awareness and Understanding: Widespread misconceptions, stigma, and a lack of basic seizure first aid knowledge persist within the general public. This often leads to delayed diagnosis, social isolation for individuals with epilepsy, and inadequate emergency responses.
- Barriers to Optimal Care: Access to specialized neurological care, particularly comprehensive epilepsy centers, remains unevenly distributed across the nation. Factors such as geographical location, insurance coverage limitations, and a shortage of trained epileptologists create significant disparities in the quality and timeliness of diagnosis and treatment.
n
n
n
n
The proposed National Plan for Epilepsy aims to systematically dismantle these barriers through a collaborative framework involving governmental agencies, healthcare providers, research institutions, advocacy groups, and individuals living with epilepsy. Its overarching goal is to foster an environment where every American affected by epilepsy receives timely diagnosis, effective treatment, and comprehensive support, ultimately leading to a better quality of life and reduced seizure burden.
n
n
Chronology: The Evolution of a Unified Vision
n
The journey towards a unified National Plan for Epilepsy has been a testament to persistent advocacy and the unwavering commitment of numerous individuals and organizations over several years. While the August 25th, 2026 publication marks a pivotal moment, the conceptualization and development of this comprehensive strategy have been an ongoing, iterative process.
n
Early Discussions and Identifying the Need (Pre-2020s): The seeds of a national plan were sown through informal discussions and shared frustrations among leaders of various epilepsy organizations. It became increasingly clear that despite individual successes in fundraising, awareness campaigns, and research initiatives, the collective impact was diluted by a lack of overarching coordination. Data consistently pointed to persistent disparities in care, lagging research funding compared to other conditions, and entrenched public misunderstanding. These early conversations highlighted the necessity of moving beyond fragmented efforts.
n
Formation of a Collaborative Consensus (Early 2020s): Recognizing the urgency, key players within the epilepsy community began to formalize their collaborative efforts. This period saw the establishment of a multi-stakeholder working group, bringing together representatives from leading advocacy groups, professional medical societies, patient organizations, and research foundations. The initial mandate was to conduct a comprehensive environmental scan, identifying the most critical unmet needs and existing gaps in the epilepsy ecosystem. This phase involved extensive data collection, literature reviews, and consultations with patients, caregivers, clinicians, and researchers.
n
Drafting Consensus Priorities and Strategic Pillars (Mid-2020s): Building upon the insights gathered, the collaborative group embarked on the challenging task of drafting consensus priorities. This involved numerous workshops, deliberative sessions, and iterative feedback loops to ensure that the proposed plan was comprehensive, actionable, and reflective of the diverse needs of the epilepsy community. Five strategic pillars emerged as the foundational elements of the plan:
n
- n
- Accelerating Research and Innovation: Focusing on basic, translational, clinical, and health services research.
- Enhancing Public Awareness and Education: Combating stigma and promoting seizure first aid.
- Improving Access to Specialized Care: Expanding the reach of comprehensive epilepsy centers and trained specialists.
- Strengthening Data Collection and Surveillance: Establishing robust national registries to better understand prevalence, incidence, and outcomes.
- Promoting Policy and Advocacy: Securing sustained governmental support and resources.
n
n
n
n
n
n
Stakeholder Engagement and Endorsement (Late 2020s): Before its formal publication, the draft National Plan underwent a rigorous process of stakeholder engagement. This included presentations at major epilepsy conferences, webinars for patient communities, and direct consultations with endorsing organizations both within and outside the epilepsy sphere. The feedback gathered during this period was instrumental in refining the plan, ensuring its practicality and broad acceptance. The overwhelming positive response and widespread endorsements solidified the conviction that the time for a national plan had arrived.
n
The Epilepsy Currents Publication (August 25th, 2026): The culmination of these extensive efforts is the publication in Epilepsy Currents. This peer-reviewed platform provides a scholarly imprimatur to the National Plan, lending it significant credibility within the medical and scientific communities. The article not only articulates the plan’s strategic objectives but also presents the compelling rationale and the collective resolve of the epilepsy community to implement this transformative vision. It marks a crucial transition from conceptualization to active implementation, signaling a new era of coordinated action.
n
n
Supporting Data: The Urgent Case for a National Plan
The urgency behind the call for a National Plan for Epilepsy is underscored by compelling data that paints a clear picture of the condition’s profound impact on American society.
Prevalence and Burden:
Epilepsy affects approximately 3.4 million Americans, with an estimated 1 in 26 people developing epilepsy at some point in their lives. This figure includes nearly 470,000 children, making it one of the most common chronic neurological conditions across all age groups. The economic burden is staggering, with direct medical costs (hospitalizations, emergency room visits, physician services, medications) and indirect costs (lost wages due to disability, premature mortality, caregiver burden) estimated to exceed tens of billions of dollars annually. Beyond the financial toll, the human cost is immeasurable, encompassing reduced quality of life, increased risk of depression and anxiety, cognitive challenges, and the potential for sudden unexpected death in epilepsy (SUDEP).
Research Funding Disparities:
A critical piece of supporting data relates to the persistent underfunding of epilepsy research. Analyses of National Institutes of Health (NIH) funding often reveal that epilepsy receives significantly less research investment per affected individual compared to conditions like Alzheimer’s disease, Parkinson’s disease, or multiple sclerosis. For example, while conditions with similar prevalence may receive hundreds of millions or even billions in annual research funding, epilepsy’s allocation has historically lagged. This disparity hinders progress in several vital areas:
- Basic Science: Understanding the fundamental mechanisms of seizure generation and propagation, identifying genetic and environmental risk factors, and exploring novel therapeutic targets.
- Translational Research: Bridging the gap between laboratory discoveries and clinical applications, including the development of new anti-seizure medications, neuromodulation devices, and gene therapies.
- Clinical Trials: Testing the efficacy and safety of new treatments, evaluating personalized medicine approaches, and refining existing therapies.
- Health Services Research: Investigating optimal models of care delivery, addressing health disparities, and ensuring equitable access to proven interventions.
- SUDEP Research: Dedicated funding to understand, predict, and prevent this devastating complication remains critically important.
Awareness and Stigma:
Surveys consistently reveal a significant lack of public understanding about epilepsy. Many Americans cannot correctly identify what to do if someone has a seizure, leading to potentially harmful interventions or delayed emergency medical attention. The social stigma associated with epilepsy often results in discrimination in employment, education, and social settings. This stigma is a major barrier to open discussion, early diagnosis, and access to support networks, contributing to mental health challenges among those affected. Educational campaigns are crucial, not just for first aid, but for fostering empathy and inclusivity.
Access to Care Disparities:
Optimal epilepsy care often requires specialized expertise found in comprehensive epilepsy centers (CECs). These centers offer multidisciplinary teams, advanced diagnostic tools (e.g., video-EEG monitoring), and surgical options for drug-resistant epilepsy. However, CECs are not uniformly distributed across the country, creating significant geographical barriers, particularly in rural and underserved urban areas. Furthermore, a shortage of trained epileptologists and neurologists, coupled with insurance restrictions, can delay or prevent access to these specialized services, leading to prolonged seizures, increased hospitalizations, and poorer long-term outcomes. The article highlights that up to 30-40% of individuals with epilepsy continue to experience seizures despite medication, underscoring the need for advanced care options that are not always accessible.
These data points collectively underscore the critical and urgent need for a coordinated, national strategy to unify efforts and maximize impact in addressing the complex challenges of epilepsy.
Official Responses: A United Front
The publication of "A Unified Vision: Forging a National Plan for Epilepsy" has been met with widespread enthusiasm and commitment from the epilepsy community, signaling a strong consensus behind this ambitious initiative.
Epilepsy Alliance America (EAA):
Epilepsy Alliance America, a driving force behind the publication, expressed immense pride in the collaborative effort. A spokesperson for EAA stated, "This publication is a testament to the power of unity and shared purpose. For too long, the fight against epilepsy has been a series of individual battles. With this National Plan, we are uniting our voices, resources, and expertise to launch a coordinated war against a condition that impacts millions. We are confident that this blueprint will serve as a catalyst for transformative change, ensuring that no one with epilepsy is left behind."
Board Members’ Contributions:
Special recognition was given to EAA Board members Amanda Mitchell, MPH, LCCE, and Joyce Bender for their invaluable contributions to the article and the broader National Plan initiative.
Amanda Mitchell, MPH, LCCE, a public health expert and certified child birth educator, commented on the plan’s public health implications: "My work has always focused on empowering individuals through education and access to vital health resources. The National Plan’s emphasis on enhancing public awareness and improving access to care resonates deeply with me. It’s about building healthier communities where epilepsy is understood, and individuals can navigate their healthcare journey with dignity and support. We must ensure that educational campaigns are not just informative but truly transformative in dismantling stigma."
Joyce Bender, a prominent advocate for individuals with disabilities and a person living with epilepsy herself, offered a powerful perspective rooted in lived experience: "For decades, I’ve seen firsthand the challenges faced by individuals with epilepsy – from employment discrimination to the emotional toll of living with unpredictable seizures. This National Plan offers a beacon of hope. It acknowledges that effective change must come from a place of deep understanding and collective action. It’s not just about medical advancements; it’s about creating a society where people with epilepsy can thrive, contribute, and live full, meaningful lives without fear or prejudice. This plan is truly about human dignity."
Collaborating Organizations:
The publication is the result of an unprecedented collaboration among leading organizations in the epilepsy field, each bringing their unique expertise to the table. Their collective endorsement and ongoing commitment are crucial for the plan’s success.
- CURE Epilepsy: Known for its unwavering focus on research, CURE Epilepsy lauded the plan’s emphasis on accelerating scientific discovery. "We believe that a cure for epilepsy is within reach, but it requires sustained, strategic investment," a representative from CURE stated. "The National Plan provides the framework to prioritize critical research areas, foster collaboration among scientists, and ultimately bring life-changing treatments to patients faster."
- American Epilepsy Society (AES): Representing medical professionals, the AES highlighted the plan’s potential to elevate clinical practice. "The National Plan’s focus on improving access to specialized care and standardizing best practices is vital for advancing the quality of epilepsy treatment," an AES spokesperson noted. "It will empower neurologists and epileptologists to provide the best possible care, ensuring that every patient benefits from the latest diagnostic tools and therapeutic interventions."
- Epilepsies Action Network (EAN): Emphasizing patient empowerment, EAN expressed optimism about the plan’s impact on advocacy and support services. "This plan gives a unified voice to the millions affected by epilepsy," said an EAN representative. "It provides a clear roadmap for patient advocacy, ensuring that the lived experiences of individuals with epilepsy are at the forefront of policy decisions and resource allocation."
- Epilepsy Foundation: A cornerstone of patient support and advocacy, the Epilepsy Foundation underscored the plan’s comprehensive nature. "From public awareness to direct patient services, the National Plan aligns perfectly with our mission to lead the fight to overcome the challenges of epilepsy," a Foundation official remarked. "It’s a holistic approach that recognizes the multifaceted needs of our community."
- National Association of Epilepsy Centers (NAEC): Representing specialized care providers, NAEC emphasized the plan’s role in strengthening the infrastructure of advanced treatment. "The plan’s strategies for expanding and supporting comprehensive epilepsy centers are crucial for ensuring that individuals with drug-resistant epilepsy receive the specialized care they desperately need," an NAEC spokesperson confirmed.
- Rare Epilepsy Network (REN): Highlighting the needs of often-overlooked populations, REN praised the plan’s inclusivity. "Rare epilepsies present unique diagnostic and treatment challenges," a REN representative stated. "The National Plan’s commitment to addressing the needs of all individuals with epilepsy, including those with rare forms, is a significant step towards equitable care and research."
- International League for Epilepsy (ILE): As a global leader, ILE recognized the plan’s potential as a model for other nations. "The ILE commends this comprehensive national effort," an ILE representative commented. "It sets a high standard for how countries can organize their resources and expertise to make a profound difference in the lives of those affected by epilepsy."
- The Epilepsy Leadership Council: This council, comprising leaders from various epilepsy organizations, reinforced the collaborative spirit. "This publication is a testament to what we can achieve when we work together," said a Council member. "The National Plan represents the collective wisdom and determination of the entire epilepsy community."
Calls for Government Engagement:
While the publication primarily represents the consensus of the epilepsy community, it explicitly calls for robust engagement from governmental bodies. The plan outlines specific recommendations for federal agencies, including increased funding appropriations for epilepsy research at the NIH, enhanced surveillance and data collection through the CDC, and policy initiatives to improve access to care through CMS and other health agencies. The hope is that this unified front will compel policymakers to recognize the immense societal benefit of investing in a national strategy for epilepsy.
Implications: A Future Transformed
The successful implementation of the National Plan for Epilepsy, as outlined in Epilepsy Currents, holds transformative implications for millions of Americans, the healthcare system, and the broader society.
For Patients and Families:
The most profound implications will be felt directly by individuals living with epilepsy and their caregivers. A national plan promises:
- Improved Quality of Life: Reduced seizure frequency and severity through better access to diagnosis and treatment, leading to greater independence, enhanced participation in daily activities, and improved mental well-being.
- Reduced Stigma and Social Isolation: Enhanced public awareness and education will foster a more understanding and inclusive society, diminishing discrimination in schools, workplaces, and social settings.
- Faster Access to Innovation: Accelerated research will translate into novel anti-seizure medications, advanced surgical techniques, and groundbreaking non-pharmacological interventions, offering new hope for those with drug-resistant epilepsy.
- Empowered Advocacy: A unified national voice will ensure that patient perspectives are central to policy-making, leading to more responsive and effective support systems.
- Hope for a Cure: While a cure remains the ultimate goal, a coordinated research agenda significantly increases the likelihood of achieving it within a foreseeable future.
For the Healthcare System:
The National Plan will instigate significant improvements within the healthcare ecosystem:
- Standardized and Equitable Care: The development of evidence-based guidelines and pathways will ensure consistent, high-quality care across diverse settings, reducing geographical and socioeconomic disparities.
- Enhanced Training and Workforce Development: Increased funding and strategic initiatives will address the shortage of neurologists, epileptologists, and specialized nurses, particularly in underserved areas, strengthening the epilepsy care workforce.
- More Efficient Resource Allocation: By identifying critical needs and prioritizing interventions, the plan will ensure that public and private resources are utilized most effectively, maximizing impact.
- Integration of Care: Promoting collaboration between primary care providers and specialists will facilitate earlier diagnosis and appropriate referrals, improving patient outcomes.
- Data-Driven Decisions: Robust national data collection and surveillance will provide invaluable insights into disease prevalence, treatment effectiveness, and healthcare utilization, informing future policy and research directions.
For the Research Community:
The scientific landscape for epilepsy research is set to undergo a significant evolution:
- Targeted Funding and Strategic Priorities: A national plan will articulate clear research priorities, guiding funding agencies and researchers towards areas with the greatest potential for impact.
- Increased Collaboration: The plan encourages multidisciplinary and multi-institutional collaborations, breaking down silos and fostering a more integrated research environment.
- Accelerated Discovery: By streamlining processes and fostering innovation, the plan aims to accelerate the pace of scientific discovery, from basic neuroscience to clinical application.
- Global Leadership: A robust national plan positions the U.S. as a leader in epilepsy research and care, potentially influencing global strategies and partnerships.
For Society at Large:
The benefits of a comprehensive National Plan extend beyond the immediate epilepsy community:
- Reduced Economic Burden: Improved seizure control and quality of life will lead to decreased healthcare costs, increased productivity, and fewer lost workdays, contributing positively to the national economy.
- Enhanced Public Health: Greater awareness and understanding of epilepsy contribute to overall public health literacy and a more compassionate society.
- Inspiration for Other Conditions: The collaborative model of the National Plan could serve as a blueprint for addressing other complex chronic conditions, demonstrating the power of unified advocacy and strategic planning.
The publication of "A Unified Vision: Forging a National Plan for Epilepsy" is more than just an article; it is a declaration of intent, a detailed roadmap, and a collective promise to the millions of Americans affected by epilepsy. It represents a pivot point, moving from individual battles to a coordinated campaign for a future where epilepsy is no longer a condition that isolates, limits, or defines. The pathway is now clear, and the call for action is resounding.
More information and a list of endorsing organizations from within and outside the epilepsy community may be found at https://www.epilepsy-national-plan.org/consensus-priorities.
